(1H-Benzo[d]imidazol-5-yl)boronic acid, 95.0%, 250mg

tert-Butyl 4-(2-amino-4-fluorophenylamino)piperidine-1-carboxylate, 95.0%, 1g

Four-necked round bottom flask Parallel side necks, 4000 ml, 45/40, 1 Piece

4-Methyl-2-(trifluoromethyl)pyrimidine-5-carboxylic acid, 95.0%, 10g

4-Bromo-1,5-naphthyridine, 95+%, 500mg

[3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-benzyl]-carbamic acid tert-butyl ester, 95.0%, 250mg

(S,E)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoate, 96%, 250mg

2,6-Dichloroisonicotinic Acid>98.0%(GC)(T)5g

(R)-3-Hydroxypyrrolidine hydrochloride, 97.0%, 1g

3-methyl-1,3-thiazolidine-4-carboxylic acid hydrochloride, 25g

Carbon Nanotube Multi-walled 20-40nm(diam.), 5-15micro m(length)5g

Carbamic acid, N-[2-[2-(2-hydroxyethoxy)ethoxy]ethyl]-, phenylmethyl ester, 95%, 1g

TERT-BUTYL 3-HYDROXY-3-(HYDROXYMETHYL)PIPERIDINE-1-CARBOXYLATE, 95.0%, 10g